Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons for human diabetes from experimental mouse models.

Rohit N Kulkarni1, Ariel Zisman

  • 1Joslin Diabetes Center, One Joslin Place, Room 602, Boston, MA 02215, USA. Rohit.Kulkarni@joslin.harvard.edu

Current Diabetes Reports
|May 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long QT syndrome and hypoglycemia in a postbariatric surgery patient with a likely pathogenic variant in <i>KCNE1</i>.

JCEM case reports·2026
Same author

Insulin/IGF signaling in islet biology and its therapeutic implications.

Endocrine reviews·2026
Same author

Proteomic analyses of human islets reveal potential markers of β cell dysfunction during prediabetes.

JCI insight·2026
Same author

Absorbable versus Non-Absorbable Sutures in Plication Surgery for Penile Curvature: A Comparison of Outcomes.

Urologia internationalis·2026
Same author

Single-Islet Proteomics Maps Pseudo-Temporal Islet Immune Responses and Dysfunction in Stage 1 Type 1 Diabetes.

bioRxiv : the preprint server for biology·2025
Same author

Exploring Size Exclusion Chromatography Columns 20 and 35 nm Pore Size Effect for Isolation of Extracellular Vesicles.

bioRxiv : the preprint server for biology·2025
Same journal

Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness.

Current diabetes reports·2026
Same journal

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease.

Current diabetes reports·2026
Same journal

Climate Change and Diabetes Outcomes: Evidence from Climate-Vulnerable Regions.

Current diabetes reports·2026
Same journal

Efficacy and safety of once-weekly basal insulin analogs versus daily basal insulin analogs in adults with type 2 diabetes: a systematic review and meta-analysis.

Current diabetes reports·2026
Same journal

Use of Glucagon-Like Peptide-1 Receptor Agonists in Women with Type 2 Diabetes Before Pregnancy: Addressing the Dilemma in A Real-World Setting.

Current diabetes reports·2026
Same journal

Can Behavioral Interventions Promote Health Equity in Pediatric Type 1 Diabetes? A Narrative Review of Promising Treatments.

Current diabetes reports·2026
See all related articles

Understanding diabetes defects is key for treatment. Genetically engineered rodent models offer crucial insights into type 1 and type 2 diabetes, advancing research where human studies are limited.

Area of Science:

  • Endocrinology and Metabolic Diseases
  • Genetics and Genomics
  • Translational Medicine

Background:

  • Type 1 and type 2 diabetes pathogenesis requires precise understanding for effective therapeutic strategies.
  • Human studies are limited, necessitating alternative research models.
  • Rodent models, particularly genetically engineered ones, have become indispensable in diabetes research.

Purpose of the Study:

  • To review recently developed rodent models for diabetes research.
  • To discuss the impact of these models on understanding human diabetes.
  • To highlight advancements in diabetes research facilitated by novel models.

Main Methods:

  • Review of scientific literature on genetically engineered rodent models for diabetes.
  • Analysis of studies showcasing the application of these models in understanding diabetes pathophysiology.

Related Experiment Videos

  • Discussion of the translational relevance of findings from rodent models to human diabetes.

    • Main Results:

    • Genetically engineered rodent models provide powerful tools to dissect complex diabetes mechanisms.
    • These models have accelerated the identification of genetic and molecular defects in both type 1 and type 2 diabetes.
    • Recent models offer unprecedented opportunities to study disease progression and test therapeutic interventions.

    Conclusions:

    • Genetically engineered rodent models are vital for advancing diabetes research and developing targeted therapies.
    • The insights gained from these models significantly contribute to our understanding of human diabetes.
    • Continued development and utilization of sophisticated rodent models will be crucial for future diabetes treatment strategies.